General description
A Certified Snap-N-Spike® Solution suited for use as starting material in calibrators and controls for a variety of LC/MS or GC/MS applications from urine drug testing and pain prescription monitoring to forensic analysis and pharmaceutical research. Dihydrocodeine is an opioid analgesic developed for treatment of moderate to severe pain and as an antitussive.
Legal Information
CERILLIANT is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Cerilliant Corporation
Molecular Weight: 337.84. Empirical Formula: C18H23NO3·HCl. grade: certified reference material. Quality Level: 300. form: liquid. feature: Snap-N-Spike®. /Snap-N-Shoot®. . packaging: ampule of 1 . mL. manufacturer/tradename: Cerilliant®. . drug control: Narcotic Licence Schedule A (Switzerland). estupefaciente (Spain). Decreto Lei 15/93: Tabela IA (Portugal). concentration: 1.0 . mg/mL in methanol (as free base). technique(s): gas chromatography (GC): suitable, liquid chromatography (LC): suitable. application(s): forensics and toxicology. format: single component solution. storage temp.: 2-8°C. SMILES string: Cl.COc1ccc2C[C@@H]3[C@@H]4CC[C@H](O)[C@@H]5Oc1c2[C@]45CCN3C. InChI: 1S/C18H23NO3.ClH/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19. /h3,6,11-13,17,20H,4-5,7-9H2,1-2H3. 1H/t11-,12+,13-,17-,18-. /m0./s1. InChI key: VMZXMTVGOAQUEN-FFHNEAJVSA-N. Pictograms: GHS02,GHS06,GHS08. Signal Word: Danger. Hazard Statements: H225 - H301 + H311 + H331 - H370. Precautionary Statements: P210 - P233 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311. Hazard Classifications: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1. Target Organs: Eyes. Storage Class Code: 3 - Flammable liquids. WGK: WGK 1. Flash Point(F): 49.5 °F - closed cup. Flash Point(C): 9.7 °C - closed cup.- UPC:
- 51191515
- Condition:
- New
- HazmatClass:
- Yes
- MPN:
- D-019-1ML
- CAS:
- 36418-29-8
- DEA:
- Yes
akash.verma@cenmed.com
(732) 447-1115





